Identification of Rare Variants in Metabolites of the Carnitine Pathway by Whole Genome Sequencing Analysis

Genetic Epidemiology

Volumn 40, Issue 6, 2016, Pages 486-491

  Yazdani, Akram ^a   Yazdani, Azam ^a   Liu, Xiaoming ^a   Boerwinkle, Eric ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

carnitine; linkage disequilibrium; metabolomics; penalization; rare variants

Indexed keywords

CARNITINE; FIBROBLAST GROWTH FACTOR 8; LYSINE;

ADULT; ARTICLE; CIS 4 DECENOYLCARNITINE GENE; COHORT ANALYSIS; ENERGY METABOLISM; FEMALE; FGF8 GENE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; HUMAN GENOME; LONGITUDINAL STUDY; LYSINE GENE; MALE; MAMMAL; MDGA2 GENE; METABOLITE; METABOLOMICS; PHENOTYPE; SEQUENCE ANALYSIS;

EID: 84981229152     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21980     Document Type: Article

References (37)

1. Ahmed SDH, Karira KA, Ahsan S. 2011. Role of L-carnitine in male infertility. J Pak Med Assoc 61(8):732–736.
2. Akaike H. 1973. Information Theory and An Extension of the Maximum Likelihood Principle. In: Petrov BN, Csaki BF, editors. Second International Symposium on Information Theory. Budapest: Academiai Kiado, pp. 267–281.
3. Bhuiyan AKMJ, Jackson S, Turnbull DM, Aynsley-Green A, Leonard JV, Bartlett K. 1992. The measurement of carnitine and acyl-carnitines: application to the investigation of patients with suspected inherited disorders of mitochondrial fatty acid oxidation. Clin Chim Acta 207(3):185–204.
4. Bremer J. 1983. Carnitine-metabolism and functions. Physiol Rev 63(4):1420–1480.
5. Burnham KP, Anderson DR. 2002. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach. New York, Springer Science & Business Media.
6. Myers RM, Stamatoyannopoulos J, Snyder M, Dunham I, Hardison RC, Bernstein BE, Gingeras TR, Kent WJ, Birney E, Wold B. and others. 2011. A user's guide to the encyclopedia of DNA elements (encode). PLoS Biol 9(4):e1001046.
7. Crossley PH, Martin GR. 1995. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121(2):439–451.
8. Demirkan A, Henneman P, Verhoeven A, Dharuri H, Amin N, van Klinken JB, Karssen LC, de Vries B, Meissner A, Gӧraler S and others. 2015. Insight in genome-wide association of metabolite quantitative traits by exome sequence analyses. PLoS Genet 11(1):e1004835.
9. Feng T, Zhu X. 2014. Whole genome sequencing data from pedigrees suggests linkage disequilibrium among rare variants created by population admixture. BMC Proc 8(Suppl 1):S44.
10. Filipek PA, Juranek J, Nguyen MT, Cummings C, Gargus JJ. 2004. Relative carnitine deficiency in autism. J Autism Dev Disord 34(6):615–623.
11. Flanagan JL, Simmons PA, Vehige J, Willcox M, Garrett Q. 2010. Role of carnitine in disease. Nutr Metab 7:30. doi: 10.1186/1743-7075-7-30.
12. Frank LE, Friedman JH. 1993. A statistical view of some chemometrics regression tools. Technometrics 35(2):109–135.
13. Fu WJ. 1998. Penalized regressions: the bridge versus the lasso. J Comp Graph Stat 7(3):379–416.
14. Hastie T, Tibshirani R, Friedman J, Franklin J. 2005. The elements of statistical learning: data mining, inference and prediction. Math Intell 27(2):83–85.
15. Hoppel C. 2003. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis 41:S4–S12.
16. Kelly GS. 1998. L-Carnitine: therapeutic applications of a conditionally-essential amino acid. Altern Med Rev 3(5):345–360.
17. Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder M J, Nickerson DA, Team ELP, Christiani DC, Wurfel MM, Lin X and others. 2012. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet 91(2):224–237.
18. Lee S, Abecasis GR, Boehnke M, Lin X. 2014. Rare-variant association analysis: study designs and statistical tests. Am J Hum Genet 95(1):5–23.
19. Li F-Y, El-Hattab AW, Bawle EV, Boles RG, Schmitt ES, Scaglia F, Wong LJ. 2010. Molecular spectrum of slc22a5 (octn2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency. Hum Mutat 31(8):E1632–E1651.
20. Morgenthaler S, Thilly WG. 2007. A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: a cohort allelic sums test (CAST). Mutat Res 615(1):28–56.
21. Nałęcz KA, Miecz D, Berezowski V, Cecchelli R. 2004. Carnitine: transport and physiological functions in the brain. Mol Aspects Med 25(5):551–567.
22. Olpin SE. 2004. Fatty acid oxidation defects as a cause of neuromyopathic disease in infants and adults. Clin Lab 51(5-6):289–306.
23. Pearson H. 2007. Meet the human metabolome. Nature 446(7131):8. doi: 10.1038/446008a.
24. Papes F, Surpili MJ, Langone F, Trigo JR, Arruda P. 2001. The essential amino acid lysine acts as precursor of glutamate in the mammalian central nervous system. FEBS Lett 488(1):34–38.
25. Rhee EP, Ho JE, Chen MH, Shen D, Cheng S, Larson MG, Ghorbani A, Shi X, Helenius IT, O'Donnell CJ and others. 2013. A genome-wide association study of the human metabolome in a community-based cohort. Cell Metab 18(1):130–143.
26. Smriga M, Ando T, Akutsu M, Furukawa Y, Miwa K, Morinaga Y. 2007. Oral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans. Biomed Res 28(2):85–90.
27. Steiber A, Kerner J, Hoppel CL. 2004. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25(5):455–473.
28. Suhre K, Wallaschofski H, Raffler J, Friedrich N, Haring R, Michael K, Wasner C, Krebs A, Kronenberg F, Chang D and others. 2011. A genome-wide association study of metabolic traits in human urine. Nat Genet 43(6):565–569.
29. Talluri R, Shete S. 2013. A linkage disequilibrium-based approach to selecting disease-associated rare variants. PLoS One 8(7):e69226.
30. The ARIC investigator. 1989. The atherosclerosis risk in communities (ARIC) study: design and objectives. Am J Epidemiol 129:687–702.
31. Verboven S, Branden KV, Goos P. 2007. Sequential imputation for missing values. Comp Biol Chem 31(5):320–327.
32. Vernez L, Dickenmann M, Steiger J, Wenk M, Krähenbühl S. 2006. Effect of L-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysis. Nephrol Dial Transplant 21(2):450–458.
33. Wen W, Li D, Li X, Gao Y, Li W, Li H, Liu J, Liu H, Chen W, Luo J and others. 2014. Metabolome-based genome-wide association study of maize kernel leads to novel biochemical insights. Nat Commun 5, 3438, doi: 10.1038/ncomms4438.
34. Yazdani A, Yazdani A, Boerwinkle E. 2015. Rare variants selection using penalization methods for the analysis of whole genome sequence data. BMC Bioinform 16(1):405. doi: 10.1186/s12859-015-0825-4.
35. Yazdani A, Dunson DB. 2015. A Bayesian hybrid method for genome-wide association studies with related individuals. Bioinformatics, doi: 10.1093/bioinformatics/btv496.
36. Yazdani A, Yazdani A, Samiei A, Boerwinkle E. 2016. Generating a robust statistical causal structure over 13 cardiovascular disease risk factors using genomics data. Journal of Biomedical Informatics. http://dx.doi.org/10.1016/j.jbi.2016.01.012.
37. Zheng Y, Yu B, Alexander D, Manolio TA, Aguilar D, Coresh J, Heiss G, Boerwinkle E, Nettleton JA. 2013. Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC study. Am J Epidemiol 178:534–542.